SOM Biotech SL
We discover, patent and develop new indications of already known drugs. 2 candidates in clinical POC and 4 in preclinical. WW patents.
Founded in 2009, SOM discovers new drug indications on a proprietary in-silico screening platform. After experimental validation of the new indications we file an international patent and develop the compound to clinical POC while it is open for license to medium-big pharmaceutical companies. Repurposing is a business of more than $20Bill sales in 2012. Business model is based on up-front payments, milestone payments and royalties.